Previously, genistein has been reported to inhibit the growth of lung cancer by downregulating essential oncoproteins, phosphorylated AKT (pAKT), and phosphorylated phosphoinositide-3 kinase (p-PI3K) (7). The gene discussed is AKT1; the disease is lung cancer.